Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis
BackgroundHepatorenal syndrome (HRS) bears a very poor prognosis with unmet need for safe and effective therapies. This systematic review and meta-analysis aimed to re-assess safety and efficacy of terlipressin versus placebo or noradrenaline for HRS, based on previous randomized controlled trials (...
Saved in:
Main Authors: | Yue-Meng Wan (Author), Song-Quan Huang (Author), Hua-Mei Wu (Author), Yu-Hua Li (Author), Hong-Jing Yin (Author), Ying Xu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetic and pharmacodynamic analyses of terlipressin in patients with hepatorenal syndrome
by: Xiaofeng Wang, et al.
Published: (2022) -
Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis
by: Po Huang, et al.
Published: (2019) -
Endothelin-1/Nitric Oxide Ratio as a Predictive Factor of Response to Therapy With Terlipressin and Albumin in Patients With Type-1 Hepatorenal Syndrome
by: Ahmed Abdel-Razik, et al.
Published: (2020) -
Hepatorenal Syndrome
by: Pınar Zeyneloğlu
Published: (2012) -
The hepatorenal protective effects of silymarin in cancer patients receiving chemotherapy: a randomized, placebo-controlled trial
by: Safoora Sadat Erfanian, et al.
Published: (2024)